No results for ‘’
Sunrest Lifescience Ltd
NSE: SUNREST BSE: 91669
₹35
(2.78%)
Wed, 10 Jun 2026, 04:09 am
Market Cap (in Cr)15.02
PE Ratio8.53
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSunrest Lifescience Cashflow
| Particulars | 2022 | 2023 | 2024 |
|---|---|---|---|
| Deprecation and amortization | -1.30M | -974.00K | -950.00K |
| Accumulated depreciation, total | — | -2.71M | -7.47M |
| Cash from operating activities | 10.96M | -150.16M | 26.17M |
| Funds from operations | 24.93M | -1.46M | 22.38M |
| Net income (cash flow) | 20.43M | 2.26M | 20.05M |
| Depreciation & amortization (cash flow) | 1.30M | 974.00K | 950.00K |
| Depreciation/depletion | 1.30M | 974.00K | 912.00K |
| Amortization | — | — | 38.00K |
| Deferred taxes (cash flow) | 0 | 0 | 0 |
| Non-cash items | -3.80M | -8.36M | -4.80M |
| Changes in working capital | -13.98M | -148.70M | 3.79M |
| Cash from investing activities | -307.00K | -71.00K | -11.45M |
| Capital expenditures | -142.00K | -71.00K | -13.71M |
| Capital expenditures - fixed assets | -142.00K | -71.00K | -13.71M |
| Capital expenditures - other assets | 0 | 0 | 0 |
| Cash from financing activities | -10.95M | 148.63M | -230.00K |
| Free cash flow | 10.81M | -150.23M | 12.45M |